NRC Health (NRC) Share buybacks
- Total buybacks · last 12 months (USD): Value $18.85M; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-30..
Share buybacks
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $18.85M | Trailing-year cash paid for share repurchases. Period ending 2026-06-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 18.85M USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-30 | $18.85M | (m) | (m) |
| 2026-03-31 | $17.20M | (m) | (m) |
| 2025-12-31 | $20.18M | (m) | (m) |
| 2025-09-30 | $27.58M | (m) | (m) |
| 2025-06-30 | $26.86M | (m) | (m) |
| 2025-03-31 | $20.87M | (m) | (m) |
| 2024-12-31 | $30.95M | (m) | (m) |
| 2024-09-30 | $38.55M | (m) | (m) |
| 2024-06-30 | $30.31M | (m) | (m) |
| 2024-03-31 | $32.13M | (m) | (m) |
| 2023-12-31 | $19.10M | (m) | (m) |
| 2023-09-30 | $6.42M | (m) | (m) |
| 2023-06-30 | $9.25M | (m) | (m) |
| 2023-03-31 | $22.91M | (m) | (m) |
| 2022-12-31 | $27.62M | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) |
| 2021-12-31 | $4.14M | (m) | (m) |
| 2015-12-31 | $1.67M | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) |
| 2010-12-31 | $399.00K | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2009-12-31 | $84.00K | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |